+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase mediated, plasmin dependent degradation of bone-like matrix



Urokinase mediated, plasmin dependent degradation of bone-like matrix



Arthritis & Rheumatism 38(9 Suppl. ): S359




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144147

Download citation: RISBibTeXText


Related references

Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. Journal of Immunology 179(5): 3297-3304, 2007

Rheumatoid synovial fibroblasts degrade cartilage matrix in a urokinase mediated, plasmin dependent way. British Journal of Rheumatology 36(Suppl. 1): 93, 1997

Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation. Biochemical Journal 355(Pt 3): 639-645, 2001

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Journal of Cell Biology 115(1): 191-199, 1991

Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Research 53(3): 693-700, 1993

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. Journal of Bone and Mineral Research 10(9): 1374-1384, 1995

Urokinase-mediated extracellular matrix degradation in human prostate carcinoma and its inhibition by retinoic acid. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 282, 1994

Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clinical Cancer Research 1(7): 755-761, 1995

Urokinase mediated degradation of extracellular matrix in vitro correlates with formation of lung metastasis in nude mice. Fibrinolysis 4(Suppl. 3): 82, 1990

The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thrombosis and Haemostasis 94(2): 304-311, 2005

Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. Febs Letters 586(16): 2366-2374, 2012

Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products. Japanese Heart Journal 23(3): 339-347, 1982

Melanoma-mediated dissolution and invasion of extra-cellular matrix Contribution of urokinase- and metalloproteinase-dependent proteolytic pathways. Molecular Biology of the Cell 3(Suppl. ): 319A, 1992

Plasmin-independent gelatinase B (matrix metalloproteinase-9) release by monocytes under the influence of urokinase. Biochemistry 66(9): 954-959, 2001